These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 1310362

  • 41. Prevalence of HTLV-1/2 infections in Spain: A cross-sectional hospital-based survey.
    Treviño A, García J, de Mendoza C, Benito R, Aguilera A, Ortíz de Lejarazu R, Ramos JM, Trigo M, Eirós JM, Rodríguez-Iglesias M, Torres A, Calderón E, Hernandez A, Gomez C, Marcaida G, Soriano V, HTLV Spanish Study Group.
    AIDS Res Hum Retroviruses; 2010 Aug; 26(8):861-4. PubMed ID: 20672999
    [Abstract] [Full Text] [Related]

  • 42. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
    Vassilev ZP, Hagan H, Lyubenova A, Tomov N, Vasilev G, Krasteva D, Des Jarlais DC.
    Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
    [Abstract] [Full Text] [Related]

  • 43. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Sep; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 44. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.
    Min JA, Yoon Y, Lee HJ, Choi J, Kwon M, Kim K, Lee CU, Kim DJ, Yun H.
    J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858
    [Abstract] [Full Text] [Related]

  • 45. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG, Cyprus IVDU Network, Kostrikis LG.
    J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
    [Abstract] [Full Text] [Related]

  • 46. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE, Malé Gil ML, HernándezSantana JF, Limiñana Cañal JM, Martín Sánchez AM.
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [Abstract] [Full Text] [Related]

  • 47. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.
    Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE.
    Am J Public Health; 1996 May; 86(5):655-61. PubMed ID: 8629715
    [Abstract] [Full Text] [Related]

  • 48. Characteristics of co-infections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1.
    Moreira M, Ramos A, Netto EM, Brites C.
    Braz J Infect Dis; 2013 May; 17(6):661-6. PubMed ID: 24029434
    [Abstract] [Full Text] [Related]

  • 49. Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain.
    Toro C, Jiménez V, Rodríguez C, Del Romero J, Rodés B, Holguín A, Alvarez P, García-Campello M, Gómez-Hernando C, Guelar A, Sheldon J, de Mendoza C, Simón A, Soriano V.
    J Med Virol; 2006 Dec; 78(12):1599-608. PubMed ID: 17063510
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L.
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users].
    Wang YC, Xu SH, Li XH, Song AJ, Jia XR, Zhuang H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):777-9. PubMed ID: 17299963
    [Abstract] [Full Text] [Related]

  • 54. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.
    Ognjan AF, Lewandowski CA, Belian BT, Burczak J, Markowitz N, Lee H, Saravolatz LD.
    Henry Ford Hosp Med J; 1992 Sep; 40(1-2):131-5. PubMed ID: 1428966
    [Abstract] [Full Text] [Related]

  • 55. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
    Guimarães Nebenzahl H, Lopes A, Castro R, Pereira F.
    S Afr Med J; 2013 Jan 24; 103(3):186-8. PubMed ID: 23472697
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors.
    Segurado AC, Braga P, Etzel A, Cardoso MR.
    AIDS Patient Care STDS; 2004 Mar 24; 18(3):135-43. PubMed ID: 15104874
    [Abstract] [Full Text] [Related]

  • 58. Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden.
    Malm K, Ekermo B, Hillgren K, Britton S, Fredlund H, Andersson S.
    Scand J Infect Dis; 2012 Nov 24; 44(11):852-9. PubMed ID: 22803699
    [Abstract] [Full Text] [Related]

  • 59. Short Communication: Current Prevalence and Risk Factors Associated with Human T Lymphotropic Virus Type 1 and Human T Lymphotropic Virus Type 2 Infections Among HIV/AIDS Patients in São Paulo, Brazil.
    Caterino-de-Araujo A, Sacchi CT, Gonçalves MG, Campos KR, Magri MC, Alencar WK, Group of Surveillance and Diagnosis of HTLV of Sa˜o Paulo (GSuDiHTLV-SP).
    AIDS Res Hum Retroviruses; 2015 May 24; 31(5):543-9. PubMed ID: 25464979
    [Abstract] [Full Text] [Related]

  • 60. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
    Imani R, Karimi A, Rouzbahani R, Rouzbahani A.
    East Mediterr Health J; 2008 May 24; 14(5):1136-41. PubMed ID: 19161086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.